Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies

The aim of our study was to investigate the immunogenicity of the BNT162b2 vaccination according to the age and medical status of vaccinated individuals. A total of 511 individuals were enrolled (median age: 54.0 years, range: 19–105); 509 of these individuals (99.6%) received two doses of BNT162b2...

Descripción completa

Detalles Bibliográficos
Autores principales: Speletas, Matthaios, Voulgaridi, Ioanna, Sarrou, Styliani, Dadouli, Aikaterini, Mouchtouri, Varvara A., Nikoulis, Dimitrios J., Tsakona, Maria, Kyritsi, Maria A., Peristeri, Athanasia-Marina, Avakian, Ioanna, Nasika, Asimina, Fragkou, Paraskevi C., Moschopoulos, Charalampos D., Zoubouneli, Stamatia, Onoufriadis, Ilias, Anagnostopoulos, Lemonia, Matziri, Alexia, Papadamou, Georgia, Theodoridou, Aikaterini, Tsiodras, Sotirios, Hadjichristodoulou, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879063/
https://www.ncbi.nlm.nih.gov/pubmed/35214774
http://dx.doi.org/10.3390/vaccines10020316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879063/
https://www.ncbi.nlm.nih.gov/pubmed/35214774
http://dx.doi.org/10.3390/vaccines10020316

Ejemplares similares